A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
The primary purpose of this study is to evaluate the efficacy and safety of lubiprostone administration in patients with opioid-induced bowel dysfunction (OBD).
Inclusion Criteria:
Exclusion Criteria:
Tempe, Arizona 85222, United States
Hagerstown, Maryland 21742, United States
Boston, Massachusetts 02215, United States
Missoula, Montana 59802, United States
Allentown, Pennsylvania 18103, United States
Portsmouth, Virginia 23707, United States